Genetic Testing Services Market

Genetic Testing Services Market Analysis by Prenatal Testing, New Born Screening, Predictive & Presymptomatic Testing, and Pharmacogenomic Testing from 2023 to 2033

Analysis of Genetic Testing Services Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033

    3.2. Global Market: Market Snapshot

4. Market Overview

    4.1. Global Market Overview

    4.2. Global Market Key Industry Developments

    4.3. Key Industry Events

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Market Revenue Projections (US$ Mn), 2023–2033

    5.7. Market: Mergers & Acquisitions

    5.8. Heat Map Analysis - Company

6. Global Market Analysis, by Test Type

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Market Size and Forecast, by Test Type

        6.3.1. Prenatal Testing Services

        6.3.2. New Born Screening

        6.3.3. Predictive and Presymptomatic Testing

        6.3.4. Pharmacogenomic Testing

        6.3.5. Others

    6.4. Global Market Analysis, by Test Type

    6.5. Global Market Attractiveness Analysis, by Test Type

7. Global Market Analysis, by Service Providers

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Market Size and Forecast, by Service Providers

        7.3.1. Hospital Based Laboratories

        7.3.2. Diagnostic laboratories

        7.3.3. Specialty Clinics

        7.3.4. Others

    7.4. Global Market Analysis, by Service Providers

    7.5. Global Market Attractiveness Analysis, by Service Providers

8. Global Market Analysis, by Applications

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Market Size and Forecast, by Applications

        8.3.1. Oncology

        8.3.2. Infectious Diseases

        8.3.3. Autoimmune Diseases

        8.3.4. Others

    8.4. Global Market Analysis, by Applications

    8.5. Global Market Attractiveness Analysis, by Applications

9. Global Market Analysis, by Region

    9.1. Introduction

    9.2. Key Insights

    9.3. Global Market Size and Forecast , by Region, 2023–2033

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

    9.4. Global Market Analysis, by Region

    9.5. Global Market Attractiveness Analysis, by Region

10. North America Market Analysis

    10.1. North America Market Key Findings

    10.2. North America Market Overview

    10.3. North America Market Size and Forecast, by Test Type

        10.3.1. Prenatal Testing Services

        10.3.2. New Born Screening

        10.3.3. Predictive and Presymptomatic Testing

        10.3.4. Pharmacogenomic Testing

        10.3.5. Others

        10.3.6. North America Market Analysis, by Test Type

    10.4. North America Market Size and Forecast, by Service Providers

        10.4.1. Hospital Based Laboratories

        10.4.2. Diagnostic laboratories

        10.4.3. Specialty Clinics

        10.4.4. Others

    10.5. North America Market Forecast, by Applications

        10.5.1. Oncology

        10.5.2. Infectious Diseases

        10.5.3. Autoimmune Diseases

        10.5.4. Others

    10.6. North America Market Forecast, by Country

        10.6.1. U.S.

        10.6.2. Canada

    10.7. North America Market Attractiveness Analysis

        10.7.1. By Test Type

        10.7.2. By Service Providers

        10.7.3. By Applications

        10.7.4. By Country

11. Europe Market Analysis

    11.1. Europe Market Key Findings

    11.2. Europe Market Overview

    11.3. Europe Market Size and Forecast, by Test Type

        11.3.1. Prenatal Testing Services

        11.3.2. New Born Screening

        11.3.3. Predictive and Presymptomatic Testing

        11.3.4. Pharmacogenomic Testing

        11.3.5. Others

    11.4. Europe Market Size and Forecast, by Service Providers

        11.4.1. Hospital Based Laboratories

        11.4.2. Diagnostic laboratories

        11.4.3. Specialty Clinics

        11.4.4. Others

    11.5. Europe Market Forecast, by Applications

        11.5.1. Oncology

        11.5.2. Infectious Diseases

        11.5.3. Autoimmune Diseases

        11.5.4. Others

    11.6. Europe Market Forecast, by Country

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Spain

        11.6.5. Italy

        11.6.6. Rest of Europe

    11.7. Europe Market Attractiveness Analysis

        11.7.1. By Test Type

        11.7.2. By Service Providers

        11.7.3. By Applications

        11.7.4. By Country

12. Asia Pacific Market Analysis

    12.1. Asia Pacific Market Key Findings

    12.2. Asia Pacific Market Overview

    12.3. Asia Pacific Cytometry Market Size and Forecast, by Test Type

        12.3.1. Prenatal Testing Services

        12.3.2. New Born Screening

        12.3.3. Predictive and Presymptomatic Testing

        12.3.4. Pharmacogenomic Testing

        12.3.5. Others

    12.4. Asia Pacific Market Size and Forecast, by Service Providers

        12.4.1. Hospital Based Laboratories

        12.4.2. Diagnostic laboratories

        12.4.3. Specialty Clinics

        12.4.4. Others

    12.5. Asia Pacific Market Forecast, by Applications

        12.5.1. Oncology

        12.5.2. Infectious Diseases

        12.5.3. Autoimmune Diseases

        12.5.4. Others

    12.6. Asia Pacific Market Forecast, by Country

        12.6.1. China

        12.6.2. India

        12.6.3. Japan

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Asia Pacific Market Attractiveness Analysis

        12.7.1. By Test Type

        12.7.2. By Service Providers

        12.7.3. By Applications

        12.7.4. By Country

13. Latin America Market Analysis

    13.1. Latin America Market Key Findings

    13.2. Latin America Market Overview

    13.3. Latin America Cytometry Market Size and Forecast, by Test Type

        13.3.1. Prenatal Testing Services

        13.3.2. New Born Screening

        13.3.3. Predictive and Presymptomatic Testing

        13.3.4. Pharmacogenomic Testing

        13.3.5. Others

    13.4. Latin America Market Size and Forecast, by Service Providers

        13.4.1. Hospital Based Laboratories

        13.4.2. Diagnostic laboratories

        13.4.3. Specialty Clinics

        13.4.4. Others

    13.5. Latin America Market Forecast, by Country

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Market Forecast, by Applications

        13.6.1. Oncology

        13.6.2. Infectious Diseases

        13.6.3. Autoimmune Diseases

        13.6.4. Others

    13.7. Latin America Market Attractiveness Analysis

        13.7.1. By Test Type

        13.7.2. By Service Providers

        13.7.3. By Applications

        13.7.4. By Country

14. Middle East & Africa Market Analysis

    14.1. Middle East & Africa Market Key Findings

    14.2. Middle East & Africa Market Overview

    14.3. Middle East & Africa Cytometry Market Size and Forecast, by Test Type

        14.3.1. Prenatal Testing Services

        14.3.2. New Born Screening

        14.3.3. Predictive and Presymptomatic Testing

        14.3.4. Pharmacogenomic Testing

        14.3.5. Others

    14.4. Middle East & Africa Market Size and Forecast, by Service Providers

        14.4.1. Hospital Based Laboratories

        14.4.2. Diagnostic laboratories

        14.4.3. Specialty Clinics

        14.4.4. Others

    14.5. Middle East & Africa Market Forecast, by Applications

        14.5.1. Oncology

        14.5.2. Infectious Diseases

        14.5.3. Autoimmune Diseases

        14.5.4. Others

    14.6. Middle East & Africa Market Size and Forecast, by Country

        14.6.1. GCC Countries

        14.6.2. Israel

        14.6.3. South Africa

        14.6.4. Rest of Middle East & Africa

    14.7. Middle East Market Attractiveness Analysis

        14.7.1. By Test Type

        14.7.2. By Service Providers

        14.7.3. By Applications

        14.7.4. By Country

15. Competition Landscape

    15.1. Global Market Share Analysis, by Company (2022)

    15.2. Company Profiles

        15.2.1. Laboratory Corporation of America Holdings

            15.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.1.2. Financials

            15.2.1.3. Recent Developments

            15.2.1.4. Strategy

        15.2.2. Quest Diagnostics Incorporated

            15.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.2.2. Financials

            15.2.2.3. Recent Developments

            15.2.2.4. Strategy

        15.2.3. Genomic Health, Inc.

            15.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.3.2. Financials

            15.2.3.3. Recent Developments

            15.2.3.4. Strategy

        15.2.4. NeoGenomics Laboratories, Inc.

            15.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.4.2. Financials

            15.2.4.3. Recent Developments

            15.2.4.4. Strategy

        15.2.5. Eurofins Scientific

            15.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.5.2. Financials

            15.2.5.3. Recent Developments

            15.2.5.4. Strategy

        15.2.6. Ambry Genetics

            15.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.6.2. Financials

            15.2.6.3. Recent Developments

            15.2.6.4. Strategy

        15.2.7. F. Hoffmann-La Roche Ltd

            15.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.7.2. Financials

            15.2.7.3. Recent Developments

            15.2.7.4. Strategy

        15.2.8. Illumina, Inc

            15.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.8.2. Financials

            15.2.8.3. Recent Developments

            15.2.8.4. Strategy

        15.2.9. CENTOGENE AG

            15.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.9.2. Financials

            15.2.9.3. Recent Developments

            15.2.9.4. Strategy

        15.2.10. 23andMe, Inc.

            15.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.10.2. Financials

            15.2.10.3. Recent Developments

            15.2.10.4. Strategy

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 02: Global Market Value (US$ Mn) Forecast, by Service Provider, 2023–2033

Table 03: Global Market Value (US$ Mn) Forecast, by Applications, 2023–2033

Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 05: North America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 06: North America Market Value (US$ Mn) Forecast, by Service Providers,

Table 07: North America Market Value (US$ Mn) Forecast, by Applications,

Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 09: Europe Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 10: Europe Market Value (US$ Mn) Forecast, by Service Providers,

Table 11: Europe Market Value (US$ Mn) Forecast, by Applications,

Table 12: Europe Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 13: Asia Pacific Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Service Providers,

Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Applications,

Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 17: Latin America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 18: Latin America Market Value (US$ Mn) Forecast, by Service Providers,

Table 19: Latin America Market Value (US$ Mn) Forecast, by Applications,

Table 20: Latin America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Test Type, 2023–2033

Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Providers,

Table 23: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Applications

Table 24: Middle East & Africa Market Value (US$ Mn) Forecast, by Country, 2023–2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Genetic Testing Services, by Test Type, Market Size (US$ Mn), 2022 (A)

Figure 02:  Global Market Revenue (%), by Service Providers, 2022 (A)

Figure 03: Distribution of Market by Region, 2023 and 2033

Figure 04: Key Industry Developments

Figure 05: Global Market Size (US$ Mn) Forecast, 2023–2033

Figure 06: Porter’s Five Forces Analysis

Figure 07: Global Market Value Share, by Test Type (2022)

Figure 08: Global Market Value Share, by Service Providers (2022)

Figure 09: Global Market Value Share, by Applications (2022)

Figure 10: Global Market Value Share Analysis, by Test Type, 2023 and 2033

Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prenatal Testing, 2023–2033

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by New Born Screening

Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Predictive and Presymptomatic Testing, 2023–2033

Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human and Tumor Genetics, 2023–2033

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2023–2033

Figure 16: Global Market Attractiveness Analysis, by Test Type

Figure 17: Global Market Value Share Analysis, by Service Provider, 2023 and 2033

Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Based Laboratories, 2023–2033

Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2023–2033

Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2023–2033

Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033

Figure 22: Global Market Attractiveness Analysis, by Service Provider

Figure 23: Global Market Value Share Analysis, by Applications, 2023 and 2033

Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2023–2033

Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease, 2023–2033

Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autoimmune Disease, 2023–2033

Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033

Figure 28: Global Market Attractiveness Analysis, by Applications

Figure 29: Global Market Scenario

Figure 30: Global Market Value Share Analysis, by Region, 2023 and 2033

Figure 31: Global Market Attractiveness Analysis, by Region

Figure 32: North America Market Size (US$ Mn) Forecast, 2023–2033

Figure 33: North America Market Attractiveness Analysis,

Figure 34: North America Market Value Share Analysis, by Test Type, 2023 and 2033

Figure 35: North America Market Value Share Analysis, by Service Providers, 2023 and 2033

Figure 36: North America Market Value Share Analysis, by Applications, 2023 and 2033

Figure 37: North America Market Value Share Analysis, by Country, 2023 and 2033

Figure 38: North America Market Attractiveness Analysis, by Test types, 2023–2033

Figure 39: North America Market Attractiveness Analysis, by Service Providers, 2023–2033

Figure 40: North America Market Attractiveness Analysis, by Applications, 2023–2033

Figure 41: Europe Market Size (US$ Mn) Forecast, 2023–2033

Figure 42: Europe Market Attractiveness Analysis,

Figure 43: Europe Market Value Share Analysis, by Test Type, 2023 and 2033

Figure 44: Europe Market Value Share Analysis, by Service Providers, 2023 and 2033

Figure 45: Europe Market Value Share Analysis, by Applications, 2023 and 2033

Figure 46: Europe Market Value Share Analysis, by Country, 2023 and 2033

Figure 47: Europe Market Attractiveness Analysis, by Test types, 2023–2033

Figure 48: Europe Market Attractiveness Analysis, by Service Providers, 2023–2033

Figure 49: Europe Market Attractiveness Analysis, by Applications, 2023–2033

Figure 50: Asia Pacific Market Size (US$ Mn) Forecast, 2023–2033

Figure 51: Asia Pacific Market Attractiveness Analysis,

Figure 52: Asia Pacific Market Value Share Analysis, by Test Type, 2023 and 2033

Figure 53: Asia Pacific Market Value Share Analysis, by Service Providers, 2023 and 2033

Figure 54: Asia Pacific Market Value Share Analysis, by Applications, 2023 and 2033

Figure 55: Asia Pacific Market Value Share Analysis, by Country, 2023 and 2033

Figure 56: Asia Pacific Market Attractiveness Analysis, by Test types, 2023–2033

Figure 57: Asia Pacific Market Attractiveness Analysis, by Service Providers, 2023–2033

Figure 58: Asia Pacific Market Attractiveness Analysis, by Applications, 2023–2033

Figure 59: Latin America Market Size (US$ Mn) Forecast, 2023–2033

Figure 60: Latin America Market Attractiveness Analysis,

Figure 61: Latin America Market Value Share Analysis, by Test Type, 2023 and 2033

Figure 62: Latin America Market Value Share Analysis, by Service Providers, 2023 and 2033

Figure 63: Latin America Market Value Share Analysis, by Applications, 2023 and 2033

Figure 64: Latin America Market Value Share Analysis, by Country, 2023 and 2033

Figure 65: Latin America Market Attractiveness Analysis, by Test types, 2023–2033

Figure 66: Latin America Market Attractiveness Analysis, by Service Providers, 2023–2033

Figure 67: Latin America Market Attractiveness Analysis, by Applications, 2023–2033

Figure 68: Middle East & Africa Market Size (US$ Mn) Forecast, 2023–2033

Figure 69: Middle East & Africa Market Attractiveness Analysis,

Figure 70: Middle East & Africa Market Value Share Analysis, by Test Type, 2023 and 2033

Figure 71: Middle East & Africa Market Value Share Analysis, by Service Providers, 2023 and 2033

Figure 72: Middle East & Africa Market Value Share Analysis, by Applications, 2023 and 2033

Figure 73: Middle East & Africa Market Value Share Analysis, by Country, 2023 and 2033

Figure 74: Middle East & Africa Market Attractiveness Analysis, by Test types, 2023–2033

Figure 75: Middle East & Africa Market Attractiveness Analysis, by Service Providers, 2023–2033

Figure 76: Middle East & Africa Market Attractiveness Analysis, by Applications, 2023–2033

Figure 77: Laboratory Corporation of America Holdings. Revenue (US$ Bn) and Y-o-Y Growth (%), 2022–2022

Figure 78: Laboratory Corporation of America Holdings. Net Sales, By Geography, 2022

Figure 79: Laboratory Corporation of America Holdings. Breakdown of Net Sales, By Segment, 2022

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Genetic Testing Services Market

Schedule a Call